The Cannabinoid Receptor Type 2 Agonist Lenabasum Improves Symptoms of Dermatomyositis

[Anonymous]

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022; 142 (10): 2554

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索